Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05844644
What this trial is testing

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObeseOverweight+1 more
Golo 100
Not applicableStudy completedNCT00714844
What this trial is testing

Insulin Detemir and Waist Circumference

Who this might be right for
Type 2 Diabetes
University of Roma La Sapienza 20
Not applicableStudy completedNCT04474795
What this trial is testing

Clinic to Community Connections - Broader Distribution

Who this might be right for
Gestational DiabetesGestational Diabetes Mellitus in Pregnancy
Washington University School of Medicine 85
Large-scale testing (Phase 3)Study completedNCT02227875
What this trial is testing

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

Who this might be right for
Type 2 Diabetes
Mylan Inc. 560
Not applicableStudy completedNCT02123901
What this trial is testing

The Effect of Walking Meditation Training on Glycemic Control and Vascular Function in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Chulalongkorn University 33
Post-approval studies (Phase 4)Study completedNCT04153981
What this trial is testing

Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 304
Not applicableStudy completedNCT01482481
What this trial is testing

Effectiveness of Nursing Care Plans Based in Nursing Diagnoses in Metabolic Control of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Risk Factors
Hospital Carlos III, Madrid 23,488
Early research (Phase 1)Study completedNCT03235219
What this trial is testing

A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 39
Not applicableStudy completedNCT05715307
What this trial is testing

Chinese Endocrinologists Health Education Study

Who this might be right for
Type 2 Diabetes
Shanghai Jiao Tong University School of Medicine 2,017
Large-scale testing (Phase 3)Study completedNCT00688701
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 361
Not applicableStudy completedNCT02862067
What this trial is testing

SGLT2 Inhibition in Diabetes and Heart Failure

Who this might be right for
Diabetes Mellitus, Type 2Heart Failure, Systolic
Virginia Commonwealth University 18
Post-approval studies (Phase 4)Study completedNCT02967211
What this trial is testing

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 609
Large-scale testing (Phase 3)Study completedNCT01113671
What this trial is testing

Type 2 Diabetes Haptoglobin Phenotype and Vitamin E

Who this might be right for
Diabetes Mellitus Type 2
Technion, Israel Institute of Technology 90
Early research (Phase 1)Ended earlyNCT00943371
What this trial is testing

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 28
Not applicableUnknownNCT00298844
What this trial is testing

Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Odense University Hospital 350
Post-approval studies (Phase 4)Study completedNCT02049034
What this trial is testing

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Surrey 8
Not applicableNot Yet RecruitingNCT07466212
What this trial is testing

QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy

Who this might be right for
CancerType 2 Diabetes
Odense University Hospital 920
Large-scale testing (Phase 3)Study completedNCT00157586
What this trial is testing

Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)

Who this might be right for
Type 2 Diabetes
Mario Negri Institute for Pharmacological Research 342
Not applicableStudy completedNCT01595269
What this trial is testing

The Clinical and Economic Impacts of e-Heath on Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Dr. Danièle Pacaud 79
Testing effectiveness (Phase 2)UnknownNCT02346669
What this trial is testing

Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Tel-Aviv Sourasky Medical Center 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation